Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minna Suvela

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Blood|October 2, 2024
Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trialSari Kytölä, Ida Vänttinen, Tanja Ruokoranta, et al.
Haematologica|December 15, 2022
<i>Ex vivo</i> venetoclax sensitivity testing predicts treatment response in acute myeloid leukemiaHeikki Kuusanmäki, Sari Kytölä, Ida Vänttinen, et al.
Cancer Discovery|September 24, 2013
Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemiaTea Pemovska, Mika Kontro, Bhagwan Yadav, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Blood|October 2, 2024
Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trialSari Kytölä, Ida Vänttinen, Tanja Ruokoranta, et al.
Haematologica|December 15, 2022
<i>Ex vivo</i> venetoclax sensitivity testing predicts treatment response in acute myeloid leukemiaHeikki Kuusanmäki, Sari Kytölä, Ida Vänttinen, et al.
Cancer Discovery|September 24, 2013
Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemiaTea Pemovska, Mika Kontro, Bhagwan Yadav, et al.
Pageof 2